NCI 8628: A randomized phase 2 study of ziv‐aflibercept and high‐dose interleukin 2 or high‐dose interleukin 2 alone for inoperable stage III or IV melanoma
暂无分享,去创建一个
J. Kirkwood | A. Chen | H. Tawbi | L. Butterfield | M. Ernstoff | T. Kuzel | S. Awasthi | P. Frankel | P. Lara | D. McDermott | K. Margolin | N. Khushalani | T. Logan | A. Tarhini | C. Ruel